At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Free account • No credit card • 5 profiles/day
The widely used Illumina email format is {first_initial}{last}@illumina.com (e.g. jsmith@illumina.com), which is used 83.68% of the time. Some other used Illumina email formats: {first}{last} (e.g. johnsmith@illumina.com)
| Illumina Email Formats | Example Email Formats | Adoption |
|---|---|---|
| {first_initial}{last} | jsmith@illumina.com |
83.68%
|
| {first}{last} | johnsmith@illumina.com |
1.04%
|
| Other formats | — |
15%
|
Adoption = share of company emails using each format — not a verification or accuracy score.
Thermo Fisher Scientific
Biotechnology Research • 10,001+ employees • Waltham, United States
Agilent Technologies
Biotechnology Research • 10,001+ employees • Les Ulis, France
PerkinElmer Optoelectronics
Biotechnology Research • 201-500 employees • United States
QIAGEN
Biotechnology Research • 5,001-10,000 employees • Manchester, United Kingdom
Illumina launched an advanced research workflow for fast and flexible detection of molecular residual disease during and following treatment.
Illumina posted revenue of $1.16 billion for Q2 2026, representing a 9.5% increase compared to Q2 2025.
New partners joined the program to use unprecedented data scale to advance more precise medicines to approval.
Illumina announced the executive appointment of Mike Sullivan as Chief Commercial Officer effective in July.
Hongli S
DirectorSenior Director, Engineering • Influencer • 5 years
Niv Mizrahi
DirectorSenior Director Software Development • Influencer • 4 years
Lijun Liu
DirectorDirector, Software Development • Influencer • 18 years
Gourav Chakraborty
DirectorAssociate Director - IT Security, Risk & Compliance • Influencer • 1 year
Launa Bilal
DirectorAssociate Director of Organizational Change Management • Influencer • 3 years
Ramesh Thamotharan
DirectorGCC Site Head & Director - Global Operations • Influencer • 1 year
Ashley Van Zeeland
HeadHead of Global Strategic Accounts • Champion • 1 year
Salilrat Napapitakkul
DirectorCountry Manager - Thailand • Influencer • 3 years
Prabha Ramakrishnan
DirectorDirector, Business Development • Influencer • 1 year
Joachim Schmid
VPVice President, Data Platforms & Multiomics • Champion • 1 year
Michael Mitchell
CXOVP, Chief Information Security Officer • Economic Buyer • 6 years
Teri Kaslow
VPVice President of Data and AI • Champion • 1 year
What is Illumina email format?
The widely used Illumina email format is {first_initial}{last} (e.g. jsmith@illumina.com) with 83.68% adoption across the company.
What is Illumina customer service number?
To contact Illumina customer service number in your country click here to find.
Who is the CEO of Illumina?
Jay Flatley is the CEO of Illumina.
Who are the decision makers in Illumina?
The decision makers in Illumina are Jay Flatley, Robert Hennessy, Ginger Hilley, etc. Click to Find Illumina decision makers emails.
